|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 27.74 USD | +0.22% |
|
-0.43% | +3.86% |
| 08-25 | Deutsche Bank Adjusts ACADIA Pharmaceuticals PT to $38 From $37, Maintains Buy Rating | MT |
| 08-25 | EU Approves Acadia Pharmaceuticals' Rett Syndrome Drug Daybu | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.22% | -0.43% | -5.61% | +30.54% | +3.86% | +16.55% | +4.88% | +72.41% | -10.14% | 4.77B | |
| -0.56% | -8.08% | -7.69% | +7.21% | -0.52% | -3.88% | +10.58% | -30.28% | +193.15% | 46.38B | |
| -2.08% | -3.57% | -1.75% | +41.03% | +155.30% | +402.72% | +533.09% | +583.53% | - | 44.51B | |
| +0.12% | -5.27% | +6.33% | +41.24% | +14.15% | +39.94% | +20.50% | -1.23% | +233.85% | 42.3B | |
| -2.62% | -5.76% | -4.79% | +29.66% | +12.50% | +8.88% | +77.44% | -2.89% | +1,028.80% | 39.91B | |
| -1.26% | -3.37% | -10.05% | +8.07% | +4.88% | +11.87% | +40.55% | -17.79% | +136.05% | 32.79B | |
| +0.16% | -3.65% | +2.19% | +24.52% | - | - | - | - | - | 17.13B | |
| -0.54% | -1.72% | -3.20% | +25.21% | +3.83% | +22.34% | +115.10% | +204.19% | +1,873.47% | 16.36B | |
| -0.03% | -3.46% | +1.26% | +8.41% | +13.65% | +12.68% | +30.90% | -43.40% | +88.22% | 14.31B | |
| -1.92% | -6.94% | -1.44% | +46.55% | +36.86% | +78.12% | +36.68% | -38.10% | +246.62% | 13.29B | |
| +3.87% | +1.29% | -0.22% | +14.59% | -9.07% | +0.15% | -33.76% | -35.98% | +120.51% | 12.31B | |
| -0.24% | -0.51% | -0.06% | +37.30% | +22.56% | +41.44% | +0.36% | -44.21% | +171.69% | 11.33B | |
| -4.14% | -9.16% | +6.68% | +18.71% | -0.52% | -24.85% | - | - | - | 11.06B | |
| -0.34% | -3.37% | -11.65% | +86.49% | +46.15% | +26.29% | +53.66% | -52.06% | - | 10.49B | |
| -0.89% | +1.16% | -9.72% | +19.26% | -16.69% | +35.91% | +490.00% | +191.57% | +2,426.45% | 10.25B | |
| -1.95% | -4.67% | -7.74% | +40.68% | +14.87% | +741.59% | +1,523.84% | +7.64% | - | 9.64B | |
| +1.36% | -0.24% | +7.75% | +49.56% | +50.37% | +169.09% | +517.74% | +75.52% | - | 9.6B | |
| -0.94% | +0.70% | +29.10% | +167.57% | +155.07% | +87.01% | +65.34% | -2.07% | +1,277.39% | 9.39B | |
| +0.05% | -2.45% | -3.23% | +37.24% | +66.20% | +151.40% | +661.99% | +222.01% | +1,070.65% | 9.39B | |
| -0.66% | -4.27% | -2.27% | -24.10% | -29.65% | -13.05% | +35.04% | +54.20% | +91.83% | 9.31B | |
| Average | -0.37% | -3.08% | -0.81% | +35.49% | +28.62% | +94.96% | +232.44% | +63.50% | +639.18% | 18.73B | |
| Weighted average by Cap. | -0.72% | -3.84% | -1.76% | +30.84% | +33.00% | +93.94% | +185.76% | +87.26% | +553.95% |
- Stock Market
- Stocks
- ACAD Stock
- Sector ACADIA Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
